Richard A. Miller, President & CEO, Director at Corvus Pharmaceuticals, holds 2.33M shares in Corvus Pharmaceuticals (Ticker: CRVS), holds ― shares in Bolt Biotherapeutics (Ticker: BOLT), holds 626.93K shares in Pharmacyclics (Ticker: PCYC). Most recently, Richard A. Miller Bought ― shares of Corvus Pharmaceuticals on May 20, 2026 for an estimated value of $83.45K.
What is the percentage of profitable transactions made by Richard A. Miller?
The percentage of profitable transactions made by Richard A. Miller is 50%.
What is the average return per transaction made by Richard A. Miller?
The average return per transaction made by Richard A. Miller is 21.10%.
What stocks does Richard A. Miller hold?
Richard A. Miller holds: CRVS, BOLT, PCYC stocks.
What was Richard A. Miller’s latest transaction?
Richard A. Miller latest transaction was an Informative Buy of $83.45K.
What was Richard A. Miller's most profitable transaction?
Richard A. Miller’s most profitable transaction was an Informative Buy of CRVS stock on June 6, 2022. The return on the trade was 238.20%.
What is Richard A. Miller's role in Corvus Pharmaceuticals?
Richard A. Miller's role in Corvus Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.